Clinical Trial Update: PNU-100480 In Newly Diagnosed, Drug Sensitive Patients With Pulmonary TB; Early Bactericidal Activity; Whole Blood Assay [Phase 2]

View source ↗

Summary

Phase 2 study of PNU-100480 in newly diagnosed, drug-sensitive pulmonary tuberculosis patients assessing early bactericidal activity using a whole-blood assay; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• PNU-100480

Snippet

Sponsor: Sequella, Inc. | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED